Cargando…

Could psychedelics open new doors for science and business? : psychedelic medicines and therapies are becoming more mainstream and may offer innovative solutions in an era of declining mental health and well-being /

Psychedelic drugs have a history clouded by stigma, but a new wave of clinical research could change how they're perceived and used. Today, a psychedelic renaissance points to potential uses of such drugs in the fields of psychiatry, mental health, and well-being. Some companies have seized upo...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Meister, Alyson (Autor), Oppegaard, Kaja (Autor), Grotefeld, Eric (Autor), Bouquet, Cyril (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: [Cambridge, Massachusetts] : MIT Sloan Management Review, 2022.
Edición:[First edition].
Temas:
Acceso en línea:Texto completo (Requiere registro previo con correo institucional)

MARC

LEADER 00000cam a22000007i 4500
001 OR_on1354561107
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu|||unuuu
008 221213s2022 mau o 000 0 eng d
040 |a ORMDA  |b eng  |e rda  |e pn  |c ORMDA  |d OCLCF  |d OCLCO 
024 8 |a 53863MIT64230 
029 1 |a AU@  |b 000073244371 
035 |a (OCoLC)1354561107 
037 |a 53863MIT64230  |b O'Reilly Media 
050 4 |a RM324.8 
082 0 4 |a 615.7/883  |2 23/eng/20221213 
049 |a UAMI 
100 1 |a Meister, Alyson,  |e author. 
245 1 0 |a Could psychedelics open new doors for science and business? :  |b psychedelic medicines and therapies are becoming more mainstream and may offer innovative solutions in an era of declining mental health and well-being /  |c Alyson Meister, Kaja Oppegaard, Eric Grotefeld, Cyril Bouquet. 
250 |a [First edition]. 
264 1 |a [Cambridge, Massachusetts] :  |b MIT Sloan Management Review,  |c 2022. 
300 |a 1 online resource (5 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a "Reprint 64230." 
520 |a Psychedelic drugs have a history clouded by stigma, but a new wave of clinical research could change how they're perceived and used. Today, a psychedelic renaissance points to potential uses of such drugs in the fields of psychiatry, mental health, and well-being. Some companies have seized upon psychedelics' potential to treat psychological conditions and spur creativity and are making business investments that they hope will pay off in breakthroughs that improve people's lives. 
590 |a O'Reilly  |b O'Reilly Online Learning: Academic/Public Library Edition 
650 0 |a Hallucinogenic drugs  |x Therapeutic use. 
650 6 |a Hallucinogènes  |x Emploi en thérapeutique. 
650 7 |a Hallucinogenic drugs  |x Therapeutic use  |2 fast 
700 1 |a Oppegaard, Kaja,  |e author. 
700 1 |a Grotefeld, Eric,  |e author. 
700 1 |a Bouquet, Cyril,  |e author. 
856 4 0 |u https://learning.oreilly.com/library/view/~/53863MIT64230/?ar  |z Texto completo (Requiere registro previo con correo institucional) 
994 |a 92  |b IZTAP